XML 34 R24.htm IDEA: XBRL DOCUMENT

Investment in Joint Venture (Tables)

3 Months Ended

Jun. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of investment activities in AFSW

The Company’s investment activities in GaNovation and AFSW for the periods presented are summarized below (in thousands):


AFSW (Joint Venture Between the Company and FSL)
April 1, 2021	$	(1,866)
Investment	2,490
Loss	(2,078)
Gain	1,455
Effect of exchange rate change	(1)
July 31, 2021	$	—

GaNovation (Joint Venture Between the Company and JCP)
August 1, 2021	$	—
Investment	2,036
Loss	(1,893)

March 31, 2022	$	143
Investment	778
Loss	(582)

June 30, 2022	$	339

Summarized unaudited financial information of GaNovation and AFSW for the periods indicated are as follows (in thousands):


	GaNovation
	June 30, 2022		March 31, 2022
Current assets	$	1,769	$	4,259
Long-term assets	$	5,248	$	3,690
Due from Transphorm	$	1,185	$	—
Other current liabilities	$	4,882	$	3,799
Due to controlling owner	$	—	$	(1)

Net surplus	$	3,320	$	4,151

	GaNovation		AFSW
	For the Three Months Ended June 30, 2022		For the Three Months Ended June 30, 2021
Sales	$	2,821	$	1,430
Gross loss	$	(2,037)	$	(2,399)
Net loss	$	(2,451)	$	(3,041)

- Definition

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

+ References + Details